Skip to main content

Clifford Chance

Clifford Chance
All
Briefings

Briefings

In this section

Drug Pricing Check-Up: A Debrief of the FTC and DOJ's Second Joint Listening Session on Lowering Americans' Drug Prices Through Competition

July 29, 2025

On July 24, 2025, the Federal Trade Commission and the U.S. Department of Justice's Antitrust Division jointly hosted the second of three mandated "listening sessions" on drug pricing. This session titled, "Formulary and Benefit Practices and Regulatory Abuse Impacting Drug Competition," focused primarily on what Chairman Ferguson perceived to be the three potential causes of reduced competition in the drug market.

Download PDF
  • Share on Twitter
  • Share on LinkedIn
  • Share via email
Back to top

Toolkits & Client Log-in